Matthias Jürgens

Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohnʼs disease and analysis of the IL17F p.His161Arg polymorphism in IBD

Julia Seiderer, Ira Elben, Julia Diegelmann et al. · Inflammatory Bowel Diseases · 2007 · 325 citations · Full text

Life Sciences, Immunology, Molecular Genetics +17

Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease

Matthias Jürgens, Jestinah Mahachie John, Isabelle Cleynen et al. · Clinical Gastroenterology and Hepatology · 2011 · 191 citations

Veterinary Medicine, Clinical Sciences, Immunology +14

Disease Activity, ANCA, and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis

Matthias Jürgens, Rüdiger P. Laubender, Franziska Hartl et al. · The American Journal of Gastroenterology · 2010 · 169 citations

Life Sciences, Immunology, Pharmacotherapy +17

Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Patients With Crohn’s Disease

David Drobne, Peter Bossuyt, Christine Breynaert et al. · Clinical Gastroenterology and Hepatology · 2014 · 131 citations

Pharmacy, Immunology, Pharmacotherapy +13

The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn’s disease independent of the IL23R genotype

Matthias Jürgens, Stephan Brand, Rüdiger P. Laubender et al. · Journal of Gastroenterology · 2010 · 54 citations

Medicine, Clinical Sciences, Immunology +16